Introduction

Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2012

Download PDF version of this entire issue, formatted for print:
2013: Volume 40, Number 1 (PDF)

Assessment of the population’s health is a core public health function. Surveillance for communicable diseases is one type of assessment. Epidemiologic surveillance is the systematic collection, analysis, and dissemination of health data for the planning, implementation, and evaluation of health programs. The Minnesota Department of Health (MDH) collects information on certain infectious diseases for the purposes of determining disease impact, assessing trends in disease occurrence, characterizing affected populations, prioritizing control efforts, and evaluating prevention strategies. Prompt reporting allows outbreaks to be recognized in a timely fashion when control measures are most likely to be effective in preventing additional cases.

In Minnesota, communicable disease reporting is centralized, whereby reporting sources submit standardized report forms to MDH. Cases of disease are reported pursuant to Minnesota Rules Governing Communicable Diseases (Minnesota Rules 4605.7000 - 4605.7800). The diseases listed in Table 1 (page 2 of the PDF) must be reported to MDH. As stated in the rules, physicians, health care facilities, laboratories, veterinarians, and others are required to report these diseases. Reporting sources may designate an individual within an institution to perform routine reporting duties (e.g., an infection preventionist for a hospital). Data maintained by MDH are private and protected under the Minnesota Government Data Practices Act (Section 13.38). Provisions of the Health Insurance Portability and Accountability Act (HIPAA) allow for routine disease reporting without patient authorization.

Since April 1995, MDH has participated as an Emerging Infections Program (EIP) site funded by the Centers for Disease Control and Prevention (CDC) and, through this program, has implemented active hospital- and laboratory-based surveillance for several conditions, including selected invasive bacterial diseases, foodborne diseases, and hospitalized influenza cases.

Isolates for pathogens with certain diseases are required to be submitted to MDH (Table 1, page 2 of the PDF). The MDH Public Health Laboratory (PHL) performs microbiologic evaluation of isolates, such as pulsed-field gel electrophoresis (PFGE), to determine whether isolates (e.g., enteric pathogens such as Salmonella and Escherichia coli O157:H7, and invasive pathogens such as Neisseria meningitidis) are related, and potentially associated with a common source. Testing of submitted isolates also allows detection and monitoring of antimicrobial resistance, which continues to be an important problem (see pp. 26-27).

Table 2 (page 3 of the PDF) summarizes cases of selected communicable diseases reported during 2011 by district of the patient’s residence. Pertinent observations for some of these diseases are presented below.

Incidence rates in this report were calculated using disease-specific numerator data collected by MDH and a standardized set of denominator data derived from U.S. Census data. Disease incidence is categorized as occurring within the seven-county Twin Cities metropolitan area (metropolitan area) or outside of it in Greater Minnesota.

• Full issue>> Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2012